<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>therapeutics &#8211; UF Innovate</title>
	<atom:link href="https://innovate.research.ufl.edu/tag/therapeutics/feed/" rel="self" type="application/rss+xml" />
	<link>https://innovate.research.ufl.edu</link>
	<description>Building business on innovation</description>
	<lastBuildDate>Tue, 12 Aug 2025 04:17:59 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://innovate.research.ufl.edu/wp-content/uploads/favicon-blue_1.png</url>
	<title>therapeutics &#8211; UF Innovate</title>
	<link>https://innovate.research.ufl.edu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Resilience To Get $164M for Site Expansion</title>
		<link>https://innovate.research.ufl.edu/resilience-164m-site-expansion-ontario/</link>
		
		<dc:creator><![CDATA[Sara Dagen]]></dc:creator>
		<pubDate>Fri, 28 May 2021 00:00:00 +0000</pubDate>
				<category><![CDATA[Accelerate @ Sid Martin Biotech]]></category>
		<category><![CDATA[News Brief]]></category>
		<category><![CDATA[Tech Licensing]]></category>
		<category><![CDATA[UF Innovate]]></category>
		<category><![CDATA[UF Startup]]></category>
		<category><![CDATA[biomanufacturing]]></category>
		<category><![CDATA[manufacturing]]></category>
		<category><![CDATA[Ology Bioservices]]></category>
		<category><![CDATA[Resilience]]></category>
		<category><![CDATA[therapeutics]]></category>
		<category><![CDATA[vaccines]]></category>
		<guid isPermaLink="false">https://scaddev1.com/resilience-164m-site-expansion-ontario/</guid>

					<description><![CDATA[Resilience, a manufacturing and technology company that recently acquired Ology Bioservices, will receive $164M to update and expand a site in Ontario.]]></description>
										<content:encoded><![CDATA[
<p>Resilience, a recently launched manufacturing and technology company for biologics and advanced therapies that recently acquired UF startup and <a href="https://innovate.research.ufl.edu/sid-martin-biotech/">UF Innovate | Sid Martin Biotech</a> graduate Ology Bioservices, will receive a $164-million investment from the Canadian government to modernize and expand the biomanufacturing site of its Mississauga, Ontario, Canada-based subsidiary, Resilience Biotechnologies Inc. (RBI).</p>



<p>This project will help increase manufacturing capacity for vaccines and therapeutics, including novel technologies such as mRNA that are now being used to fight COVID-19.</p>



Read more about <a href="https://www.dcatvci.org/supplier-news/7161-resilience-to-get-164-m-from-canadian-gov-t-for-biomfg-site-expansion">Resilience To Get $164M for Site Expansion.</a>



<hr class="wp-block-separator" />



<figure class="wp-block-embed is-type-wp-embed is-provider-uf-innovate wp-block-embed-uf-innovate"><div class="wp-block-embed__wrapper">
<blockquote class="wp-embedded-content" data-secret="bCE3JBBhhI"><a href="https://innovate.research.ufl.edu/2021/04/13/resilience-acquires-ology-bioservices/">Resilience Acquires Biologics Manufacturing Company Ology Bioservices</a></blockquote><iframe class="wp-embedded-content" sandbox="allow-scripts" security="restricted"  title="&#8220;Resilience Acquires Biologics Manufacturing Company Ology Bioservices&#8221; &#8212; UF Innovate" src="https://innovate.research.ufl.edu/2021/04/13/resilience-acquires-ology-bioservices/embed/#?secret=P1Pcf9ASNM#?secret=bCE3JBBhhI" data-secret="bCE3JBBhhI" width="600" height="338" frameborder="0" marginwidth="0" marginheight="0" scrolling="no"></iframe>
</div></figure>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
